Madrigal Pharmaceuticals Reports 2020 Fourth Quarter and Full Year Financial Results and Highlights yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Goldman Sachs says Americans have added $1 trillion to money market mutual funds in the pandemic.
That means retail traders influence on the market should only grow in the months ahead.
Goldman says that money could continue to blow up big short bets, just like it did with GameStop.
The GameStop short squeeze and stock bonanza might have felt like a once-a-decade or once-in-a-lifetime event, but Goldman Sachs says it could happen again, and soon.
Even if there were many ways the social media-fueled frenzy in GameStop and AMC Networks and Bed Bath & Beyond was unique, many of its most notable ingredients are still there, according to Goldman Sachs. Chief among them are these two: There are a lot of big short bets on the market, and retail investors still have a ton of money.
So Microcap Biotechs Is Where The Market Insanity Is Next zerohedge.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zerohedge.com Daily Mail and Mail on Sunday newspapers.
ResearchAndMarkets.com’s offering.
Sales for the NASH market to grow from $144.4M in 2019 to $27.2B in 2029 at a Compound Annual Growth Rate (CAGR) of 68.8% across the 7MM.
At the end of 2029, the US will contribute around 94.3% of global sales, while the 5EU and Japan will account for around 4.5% and 1.2% of sales, respectively.
Non-alcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of steatosis (fatty liver), in addition to liver inflammation and damage. Unlike alcoholic liver disease, NASH occurs in those who drink little or no alcohol. NASH usually presents with few or no symptoms, and most people affected with the disease feel healthy and are unaware they have a problem. However, symptoms including fatigue, weight loss, and weakness emerge once the disease has progressed to a more advanced stage, like cirrhosis. NASH is suspected if elevated liver enzymes are detected during routine blood panels, but it is only